GPX1 and urinary bladder neoplasm: In 2013, M. Cao et al. performed a meta-analysis, which also showed that the GPX1 (rs1050450) polymorphism was associated with the occurrence of bladder neoplasms (nonCC versus CC: OR 1.876, 95% Cl 1.011–3.480, p-value <0.001) [42].